SCHEMBL30045127

SCHEMBL30045127

CCN1CCN(c2cc(NC(=O)OC(C)(C)C)c(N)cc2C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 3/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
GFER P55789 1/20 0.44
ALDH1A1 P00352 4/20 0.40
APOBEC3A P31941 2/20 0.40
RAB9A P51151 2/20 0.40
APOBEC3G Q9HC16 2/20 0.40
CYP2D6 P10635 3/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 1/20 0.39
CHRM1 P11229 2/20 0.39
CHRM5 P08912 1/20 0.39
DRD2 P14416 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C19 P33261 1/20 0.38
OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23606830 1.00 RAD52 (0.44) RAD52GAAMAPTGFERALDH1A1
SCHEMBL21600750 0.88 CYP2D6 (0.48) CYP2D6NPC1CHRM1CHRM5CHRM2
SCHEMBL30043999 0.88 ALDH1A1 (0.46) MAPTALDH1A1RAB9ACYP2D6NPC1
SCHEMBL23606371 0.88 ALDH1A1 (0.46) MAPTALDH1A1RAB9ACYP2D6NPC1
SCHEMBL23606834 0.87 WDR5 (0.41) GAAALDH1A1MEN1KMT2ALMNA
SCHEMBL30044351 0.87 WDR5 (0.41) GAAALDH1A1MEN1KMT2ALMNA
SCHEMBL6164845 0.87 MAPT (0.40) GAAMAPTALDH1A1RAB9APOLB
SCHEMBL25139777 0.85 AAK1 (0.36) GAAMAPTALDH1A1RAB9ANPC1
SCHEMBL16071685 0.82 GAA (0.51) RAD52GAAMAPTGFERALDH1A1
SCHEMBL28532484 0.81 GAA (0.44) RAD52GAAMAPTGFERALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12582654-B2 Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereof BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2026-03-24 US disclosed
EP-4083021-B1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2025-07-02 EP disclosed
US-20230125046-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2023-04-20 US disclosed
EP-4083021-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230125046-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF FGFR4, FGFR1, WEE1 RAD52 4495/4885GAA 3528/4885MAPT 3251/4885
US-12582654-B2 Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereof FGFR4, FGFR3, FGFR1 RAD52 4379/4885GAA 4446/4885MAPT 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.